Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1982 3
1983 2
1984 1
1985 2
1986 3
1987 1
1988 2
1989 2
1990 1
1991 2
1992 4
1993 1
1994 4
1995 2
1996 3
1997 11
1998 2
1999 6
2000 8
2001 7
2002 7
2003 1
2004 5
2005 2
2006 7
2007 8
2008 15
2009 10
2010 12
2011 6
2012 16
2013 19
2014 28
2015 5
2016 10
2017 12
2018 10
2019 10
2020 12
2021 16
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Results by year
Filters applied: . Clear all
Page 1
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM; Children's Oncology Group. Yu AL, et al. N Engl J Med. 2010 Sep 30;363(14):1324-34. doi: 10.1056/NEJMoa0911123. N Engl J Med. 2010. PMID: 20879881 Free PMC article. Clinical Trial.
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. Mody R, et al. Among authors: yu al. J Clin Oncol. 2020 Jul 1;38(19):2160-2169. doi: 10.1200/JCO.20.00203. Epub 2020 Apr 28. J Clin Oncol. 2020. PMID: 32343642 Free PMC article. Clinical Trial.
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Sondel PM, Bender JG, Maris JM, Park JR, Bagatell R. Mody R, et al. Among authors: yu al. Lancet Oncol. 2017 Jul;18(7):946-957. doi: 10.1016/S1470-2045(17)30355-8. Epub 2017 May 23. Lancet Oncol. 2017. PMID: 28549783 Free PMC article. Clinical Trial.
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Yu AL, Gilman AL, Ozkaynak MF, Naranjo A, Diccianni MB, Gan J, Hank JA, Batova A, London WB, Tenney SC, Smith M, Shulkin BL, Parisi M, Matthay KK, Cohn SL, Maris JM, Bagatell R, Park JR, Sondel PM. Yu AL, et al. Clin Cancer Res. 2021 Apr 15;27(8):2179-2189. doi: 10.1158/1078-0432.CCR-20-3909. Epub 2021 Jan 27. Clin Cancer Res. 2021. PMID: 33504555 Free PMC article. Clinical Trial.
Targeting glycosphingolipids for cancer immunotherapy.
Yu J, Hung JT, Wang SH, Cheng JY, Yu AL. Yu J, et al. Among authors: yu al. FEBS Lett. 2020 Nov;594(22):3602-3618. doi: 10.1002/1873-3468.13917. Epub 2020 Sep 9. FEBS Lett. 2020. PMID: 32860713 Free article. Review.
Promising therapeutic targets in neuroblastoma.
Matthay KK, George RE, Yu AL. Matthay KK, et al. Among authors: yu al. Clin Cancer Res. 2012 May 15;18(10):2740-53. doi: 10.1158/1078-0432.CCR-11-1939. Clin Cancer Res. 2012. PMID: 22589483 Free PMC article. Review.
Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer.
Lin WD, Fan TC, Hung JT, Yeo HL, Wang SH, Kuo CW, Khoo KH, Pai LM, Yu J, Yu AL. Lin WD, et al. Among authors: yu al. Cancer Immunol Res. 2021 Jan;9(1):113-122. doi: 10.1158/2326-6066.CIR-20-0203. Epub 2020 Nov 11. Cancer Immunol Res. 2021. PMID: 33177111
COVID-19 in the state of São Paulo: the evolution of a pandemic.
Lorenz C, Ferreira PM, Masuda ET, Lucas PCC, Palasio RGS, Nielsen L, Monteiro PCM, Trevisan CM, Yu ALF, Carvalhanas TRMP. Lorenz C, et al. Among authors: yu alf. Rev Bras Epidemiol. 2021 Sep 6;24:e210040. doi: 10.1590/1980-549720210040. eCollection 2021. Rev Bras Epidemiol. 2021. PMID: 34495193 Free article. English, Portuguese.
SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.
Yu ALF, Liphaus BL, Ferreira PM, Tanamachi AT, Masuda ET, Trevisan CM, Lucas PCC, Bugno A, Carvalhanas TRMP. Yu ALF, et al. Rev Inst Med Trop Sao Paulo. 2021 Jun 18;63:e50. doi: 10.1590/S1678-9946202163050. eCollection 2021. Rev Inst Med Trop Sao Paulo. 2021. PMID: 34161556 Free PMC article.
269 results